Annual Cash & Cash Equivalents
$82.55 M
+$34.20 M+70.75%
December 31, 2023
Summary
- As of February 7, 2025, ANRO annual cash & cash equivalents is $82.55 million, with the most recent change of +$34.20 million (+70.75%) on December 31, 2023.
- During the last 3 years, ANRO annual cash & cash equivalents has risen by +$56.84 million (+221.14%).
- ANRO annual cash & cash equivalents is now at all-time high.
Performance
ANRO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$181.70 M
-$11.42 M-5.91%
September 30, 2024
Summary
- As of February 7, 2025, ANRO quarterly cash and cash equivalents is $181.70 million, with the most recent change of -$11.42 million (-5.91%) on September 30, 2024.
- Over the past year, ANRO quarterly cash and cash equivalents has increased by +$99.15 million (+120.12%).
- ANRO quarterly cash and cash equivalents is now -11.75% below its all-time high of $205.90 million, reached on March 31, 2024.
Performance
ANRO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ANRO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.8% | +120.1% |
| 3 y3 years | +221.1% | - |
| 5 y5 years | +221.1% | - |
ANRO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +221.1% | -11.8% | +275.9% |
| 5 y | 5-year | at high | +221.1% | -11.8% | +275.9% |
| alltime | all time | at high | +221.1% | -11.8% | +275.9% |
Alto Neuroscience Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $181.70 M(-5.9%) |
| Jun 2024 | - | $193.12 M(-6.2%) |
| Mar 2024 | - | $205.90 M(+149.4%) |
| Dec 2023 | $82.55 M | $82.55 M(+60.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $51.29 M(+6.1%) |
| Dec 2022 | $48.34 M(+88.1%) | - |
| Dec 2022 | - | $48.34 M |
| Dec 2021 | $25.70 M | - |
FAQ
- What is Alto Neuroscience annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Alto Neuroscience?
- What is Alto Neuroscience annual cash & cash equivalents year-on-year change?
- What is Alto Neuroscience quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Alto Neuroscience?
- What is Alto Neuroscience quarterly cash and cash equivalents year-on-year change?
What is Alto Neuroscience annual cash & cash equivalents?
The current annual cash & cash equivalents of ANRO is $82.55 M
What is the all time high annual cash & cash equivalents for Alto Neuroscience?
Alto Neuroscience all-time high annual cash & cash equivalents is $82.55 M
What is Alto Neuroscience annual cash & cash equivalents year-on-year change?
Over the past year, ANRO annual cash & cash equivalents has changed by +$34.20 M (+70.75%)
What is Alto Neuroscience quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ANRO is $181.70 M
What is the all time high quarterly cash and cash equivalents for Alto Neuroscience?
Alto Neuroscience all-time high quarterly cash and cash equivalents is $205.90 M
What is Alto Neuroscience quarterly cash and cash equivalents year-on-year change?
Over the past year, ANRO quarterly cash and cash equivalents has changed by +$99.15 M (+120.12%)